Company Overview of RNL Europe GmbH
As of 2013, RNL Europe GmbH went out of business. RNL Europe GmbH operates as a research organization that develops stem cell-based therapies for the treatment of autoimmune disorders. The company was formerly known as Pharmicell Europe GmbH and changed its name to RNL Europe GmbH, following its acquisition by K-STECMCELL CO.,Ltd. in January 2011. RNL Europe GmbH was founded in 2006 and is based in Berlin, Germany.
Founded in 2006
49 30 3393 5994
49 30 3393 5996
Key Executives for RNL Europe GmbH
RNL Europe GmbH does not have any Key Executives recorded.
Similar Private Companies By Industry
|Combinature Biopharm AG||Europe|
|Soluvance NanoScience AG||Europe|
|Signature Diagnostics AG||Europe|
|Deutsche Gesellschaft für Humanplasma mbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact RNL Europe GmbH, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.